North Brunswick, NJ, United States of America

Yon W Ebright

This inventor holds 20 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Antibacterial Agents. Top assignees: Rutgers, The State University of New Jersey, Provid Pharmaceuticals Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yon W Ebright. Retrieved from https://idiyas.com/inventor/yon-w-ebright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 65.0

 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 125(Granted Patents)


Location History:

  • North Brunswick, NJ (US) (2005 - 2008)
  • New Brunswick, NJ (US) (2015 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial Agents
Pyronins
RNA Polymerase Inhibitors
Salinamide Derivatives
High-Potency Derivatives
Fluorescent Labeling
Bipartite Inhibitors
Multi-Label Labeling
Bis-Transition-Metal-Chelate Probes
Aryl Myxopyronin Derivatives
Dual-Targeted Inhibitors
High-Specificity Labeling
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yon W. Ebright in Antibacterial Research

Introduction: Yon W. Ebright, a prominent inventor based in North Brunswick, NJ, has made significant strides in the field of antibacterial research. With a remarkable portfolio of 20 patents, his work has greatly contributed to the advancement of medical science, particularly in the development of novel antibacterial agents.

Latest Patents: Ebright’s latest patents include groundbreaking inventions centered around antibacterial agents. One noteworthy patent is the development of "Antibacterial agents: soluble salts and aqueous formulations of pyronins." This invention features salts of specific formulas that can be utilized as inhibitors of bacterial RNA polymerase, showcasing potential applications as effective antibacterial agents.

Another important invention is titled "Antibacterial agents: O-alkyl-deuterated pyronins." Similar to his previous work, this patent introduces compounds that can serve as inhibitors of bacterial RNA polymerase and enhances the understanding of antibacterial mechanisms. Both patents focus on novel methods of making and using compounds that can significantly impact the fight against bacterial infections.

Career Highlights: Ebright has had an illustrious career, having worked with esteemed institutions like Rutgers, the State University of New Jersey, and Provid Pharmaceuticals Inc. His role in these organizations has facilitated cutting-edge research that bridges the gap between theoretical science and practical applications.

Collaborations: Throughout his career, Ebright has collaborated with distinguished colleagues, including Richard H. Ebright and David Degen. These partnerships have fostered an innovative environment conducive to the exploration and development of new antibacterial solutions, underscoring the importance of teamwork in scientific advancement.

Conclusion: Yon W. Ebright's contributions to antibacterial research through his patented inventions highlight the vital role of innovation in the healthcare industry. His dedication to developing effective antibacterial agents paves the way for future breakthroughs, positioning him as a key figure in the ongoing battle against infectious diseases. With a solid foundation in research and collaborative efforts, Ebright continues to inspire the next generation of inventors and scientists.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…